NASDAQ:OLMA

Olema Pharmaceuticals Stock Insider Trading

etoro logo Buy OLMA
*Your capital is at risk
$10.51
-0.180 (-1.68%)
At Close: Jun 03, 2026

Olema Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -50.62. In total, the insiders bought 3.91M and sold 1.26M OLMA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-50.62
Buy 3.91M shares
Sell 1.26M shares
64% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Feb 02, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -50.62.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Sep 18, 2025
Sell
Common Stock
S-Sale
Harmon Cyrus
Director
Director 10 000
Value: $83.3K
Sep 16, 2025
Sell
Common Stock
S-Sale
Harmon Cyrus
Director
Director 10 000
Value: $80.4K
Sep 16, 2025
Sell
Common Stock
S-Sale
Harmon Cyrus
Director
Director 1 914
Value: $15.5K
Sep 16, 2025
Sell
Common Stock
S-Sale
Harmon Cyrus
Director
Director 1 914
Value: $15.5K
Sep 16, 2025
Sell
Common Stock
S-Sale
Harmon Cyrus
Director
Director 10 000
Value: $80.4K
Jun 11, 2025
Buy
Stock Option (Right to buy)
A-Award
Bvf Partners L P/il
See Explanation Of Responses
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Larson Yi
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Garland J. Scott
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Horning Sandra
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Clark Ian T
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Hrustanovic Gorjan
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Graham G. Walmsley
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Harmon Cyrus
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Butitta Cynthia M
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Rappaport Andrew
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Rappaport Andrew
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Butitta Cynthia M
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Harmon Cyrus
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Graham G. Walmsley
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Hrustanovic Gorjan
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Clark Ian T
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Horning Sandra
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Garland J. Scott
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (right to buy)
A-Award
Larson Yi
Director
Director 24 150
Value: $98.5K
Jun 11, 2025
Buy
Stock Option (Right to buy)
A-Award
Bvf Partners L P/il
See Explanation Of Responses
Director 24 150
Value: $98.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT OLEMA PHARMACEUTICALS INC
Olema Pharmaceuticals
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negativ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE